CTD Holdings Inc. (NASDAQ: CYTH) a biotechnology company that develops cyclodextrin-based products for the treatment of diseases rushed in the pre-market session more than 70% to $8.15 after the Analysts from the Maxim Group upgraded the stock to BUY with the price of $12.00.
CTD Holdings Inc. (NASDAQ: CYTH) stock has a Market Cap of 8.01M managed the weekly performance of 12.86% in contrast with monthly performance of -56.51%.
Read More
